OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Enhancing Therapeutic Drug Monitoring in Inflammatory Bowel Disease: A Comparative Analysis of Rapid Point-of-Care Infliximab, Adalimumab and Anti-Drug Antibodies’ Determination against ELISA
Francisco José Toja-Camba, Laura García‐Quintanilla, Lorena Rodríguez-Martínez, et al.
Pharmaceutics (2023) Vol. 15, Iss. 11, pp. 2615-2615
Open Access | Times Cited: 6
Francisco José Toja-Camba, Laura García‐Quintanilla, Lorena Rodríguez-Martínez, et al.
Pharmaceutics (2023) Vol. 15, Iss. 11, pp. 2615-2615
Open Access | Times Cited: 6
Showing 6 citing articles:
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology
Dahham Alsoud, Dirk Jan A. R. Moes, Zhigang Wang, et al.
Therapeutic Drug Monitoring (2024) Vol. 46, Iss. 3, pp. 291-308
Closed Access | Times Cited: 5
Dahham Alsoud, Dirk Jan A. R. Moes, Zhigang Wang, et al.
Therapeutic Drug Monitoring (2024) Vol. 46, Iss. 3, pp. 291-308
Closed Access | Times Cited: 5
Therapeutic drug monitoring and immunogenetic factors associated with the use of adalimumab in Crohn’s disease patients
Lívia Moreira Genaro, Juliana Carron, Marina Moreira de Castro, et al.
International Journal of Immunopathology and Pharmacology (2025) Vol. 39
Open Access
Lívia Moreira Genaro, Juliana Carron, Marina Moreira de Castro, et al.
International Journal of Immunopathology and Pharmacology (2025) Vol. 39
Open Access
Model-informed precision dosing in inflammatory bowel diseases
Arno R. Bourgonje, Marla C. Dubinsky, Ron J. Keizer, et al.
Trends in Pharmacological Sciences (2024)
Closed Access
Arno R. Bourgonje, Marla C. Dubinsky, Ron J. Keizer, et al.
Trends in Pharmacological Sciences (2024)
Closed Access
Lateral flow test versus enzyme‐linked immunosorbent assay to measure infliximab trough concentrations: A head‐to‐head comparison
Marleen Bouhuys, Margreet Wessels, Willemien de Vries, et al.
Journal of Pediatric Gastroenterology and Nutrition (2024)
Open Access
Marleen Bouhuys, Margreet Wessels, Willemien de Vries, et al.
Journal of Pediatric Gastroenterology and Nutrition (2024)
Open Access
Potential Prognostic Protein Biomarkers in Tears From Noninfectious Uveitis Patients Under Biologic Treatment as a Prelude to Personalized Medicine
Lorena Rodríguez-Martínez, Carmen Antía Rodríguez-Fernández, Olalla Rodríguez Lemos, et al.
Investigative Ophthalmology & Visual Science (2024) Vol. 65, Iss. 13, pp. 29-29
Open Access
Lorena Rodríguez-Martínez, Carmen Antía Rodríguez-Fernández, Olalla Rodríguez Lemos, et al.
Investigative Ophthalmology & Visual Science (2024) Vol. 65, Iss. 13, pp. 29-29
Open Access
Evaluating the Accuracy and Clinical Utility of AFIAS-10 Point of Care Versus Enzyme-Linked Immunosorbent Assay in Therapeutic Drug Monitoring of Infliximab and Adalimumab
Carles Iniesta Navalón, Manuel Ríos-Saorín, Rebeca Añez-Castaño, et al.
Therapeutic Drug Monitoring (2024)
Closed Access
Carles Iniesta Navalón, Manuel Ríos-Saorín, Rebeca Añez-Castaño, et al.
Therapeutic Drug Monitoring (2024)
Closed Access
